Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Refractory OCD
NCT05015595Phase 3Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Sep 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of memantine in obsessive compulsive disorder (OCD), sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
memantine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT05015595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05015595.